NAPLEX Exam Prep icon

6.0 by Tortoises Inc


May 5, 2024

About NAPLEX Exam Prep

NAPLEX Exam Prep App is providing total 3000+ multiple choice questions.

NAPLEX Exam Prep Free App Designed to help better prepare for your North American Pharmacist Licensure Examination (NAPLEX). In NAPLEX Exam Prep Free App is providing total 3000+ multiple choice questions.

Questions from Following chapters:

• Herbs and Dietary Supplements

• Laboratory Tests

• Antiinfective Agents

• Cardiovascular Disorders

• Dermatologic Disorders

• Common Endocrinologic Disorders

• Gastrointestinal Disorders

• Geriatrics

• Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)

• Kidney Disorders

• Pain Management

• Psychiatric Disorders

• Respiratory Disorders

• Arthritis

• Seizure Disorders

• Women’s Health Issues

• Immunology and Vaccines

• Immunosuppressants

• Nonprescription Products

• Nutrition

• Basic Pharmacokinetics

• Pharmacogenomics

• Toxicology

App Features:

• NAPLEX Exam Prep Free App is providing total 3000+ multiple choice questions.

• NAPLEX Quiz Questions Practice anywhere, anytime, even without a connection

• Timer is Started When you start Quiz

Disclaimer: This app is not affiliated with or endorsed by NABP or NAPLEX

What's New in the Latest Version 6.0

Last updated on May 5, 2024

Added new questions
Improved app performance
Updated for Android-14

Translation Loading...

Additional APP Information

Latest Version

Request NAPLEX Exam Prep Update 6.0

Uploaded by

Iykeymani Jonas

Requires Android

Android 8.0+

Available on

Get NAPLEX Exam Prep on Google Play

Show More

NAPLEX Exam Prep Screenshots

Comment Loading...
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.